Updated Jul 16, 2026
FISCHER JOST has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Jost Fischer is listed as a Director of AEON Biopharma, Inc. in SEC filings dated around June 22, 2026. Public biographical information about Fischer is not widely available, and there are no obvious indicators of broad public notability or wealth in the available SEC context. There is no clear evidence in the provided filings that he is deceased as of the most recent filing date.
| Role | Director |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | AEON | AEON Biopharma, Inc. | A — Grant or award | 222.7K | $0.00 |
Jost Fischer is listed as a Director of AEON Biopharma, Inc. in SEC filings dated around June 22, 2026. Public biographical information about Fischer is not widely available, and there are no obvious indicators of broad public notability or wealth in the available SEC context. There is no clear evidence in the provided filings that he is deceased as of the most recent filing da…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live FISCHER JOST profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.